PainShield by NanoVibronix gains Canadian Medical Device License

Top Quote Therapeutic Devices Bureau in Canada has granted the medical device license allowing Nanovibronix Ltd. to commence with PainShieldTM product sales in Canada. End Quote
  • (1888PressRelease) September 26, 2011 - Santι, Canada - Therapeutic Devices Bureau has granted the medical device license allowing Nanovibronix Ltd. to commence with PainShieldTM product sales in Canada and to seek for a local distributor to promote and sell PainShieldTM therapeutic ultrasound device within Canada.

    The PainShieldTM portable ultrasound product generates and delivers localized, low intensity, low frequency therapeutic ultrasound within a self adhering patch that is placed next to the treated area for a period of time.

    This novel approach of delivering Low Intensity and Low Frequency (LILF) ultrasound allows for longer and more effective treatments. Unlike traditional ultrasound, the Surface Acoustic Waves (SAW) are characterized by elliptical particle movement travelling across bony surfaces with great efficiency. When the device is applied to a bony surface, such as the forehead, the LILF/SAW will travel and reach the entire skull surface and be effectively and efficiently transmitted via the Cerebrospinal fluid to the central nervous system (CNS) structures juxtaposed against the bony structures.

    Product can be used in a wide range of applications, including:
    • Reduction of acute and chronic pain (e.g. in the case of Trigeminal Neuralgia
    • CTS (Carpal Tunnel Syndrome)
    • Heel Spur
    • Various Musculoskeletal injuries and for post operational treatment.
    • Treatment for Tendon injury, (tendonitis elbow, tendonitis knee, Achilles Tendonitis, tendonitis shoulder, tendonitis wrist)
    PainShieldTM can be used immediately in the post-injury and post-op period. The patch based device does not require medical personnel to apply and hold it in place while getting therapy.

    Patient benefits from using PainShieldTM portable therapeutic device:

    • Ease of application and use
    • Faster recovery time
    • High compliance
    • Safety
    • Effectiveness.

    PainShieldTM has received CE Mark and FDA clearance and from now on it's allowed for distribution and promotion on the territory of Canada.
    Contact: Amir Rippel, VP Marketing
    NanoVibronix Ltd.
    Tel.: +972-4-8200581
    Email: info ( @ ) nanovibronix dot com

  • FB Icon Twitter Icon In-Icon
Contact Information